Latest Working Capital News

New Zealand King Salmon Investments Limited reported a significant interim loss driven by biological asset valuation pressures and operational costs, while announcing a strategic $8.14 million property purchase.

Rewardle Holdings addresses ASX queries on its CloudHolter investment, convertible note funding, and financial restatements, while outlining its going concern status despite operational losses.

RareX has locked in a A$50 million equity funding facility with GEM Global Yield to back its Mrima Hill rare earths project in Kenya, contingent on project approval. This deal strengthens RareX’s international partnerships and provides flexible capital to advance its development plans.

Swift Networks Group has completed an oversubscribed $1.6 million placement to fund the rollout of its Swift TV platform, with strong backing from insiders and major shareholders.

Rewardle Holdings has arranged a $2 million revolving standby debt facility with Temorex, secured by its CloudHolter shares, offering fresh working capital and flexible fee payment options.

KMD Brands reported a modest 1% sales increase in FY25 but faced a sharp 65% drop in underlying EBITDA, prompting a bold 'Next Level' turnaround strategy targeting margin expansion and debt reduction in FY26.

Range International has raised A$1.57 million through a discounted share placement to fund growth initiatives in Indonesia and the Philippines, alongside a key board appointment.

Way2VAT Ltd has secured a strategic acquisition of UK-based RBC VAT Limited alongside a $4.1 million placement, accelerating its expansion in VAT compliance and consultancy services.

Kula Gold has raised $2.5 million through a strategic placement to key investors, aiming to accelerate exploration at its Mt Palmer Gold Project amid a change in joint venture ownership.

Kula Gold has raised $2.5 million through a strategic share placement to key industry players, aiming to accelerate exploration at its Mt Palmer Gold Project.

Altamin Limited has successfully closed the institutional tranche of its 45-for-100 entitlement offer, raising $3.43 million with full participation from its major shareholder, the Victor Smorgon Group. The retail offer opens on 29 September, presenting shareholders with a chance to invest at the same price.

Noxopharm Limited has secured an extension on $2.6 million of convertible notes and obtained a $1.25 million unsecured loan to bolster working capital, pending shareholder approval.